Emletra Junior 25 mg/100 mg Tablet

Emletra Junior 25 mg/100 mg Tablet

Welcome to the information page for Emletra Junior 25 mg/100 mg Tablet, brought to you by Emcure Pharmaceuticals Ltd. This product contains the active ingredient Ritonavir (25mg) + Lopinavir (100mg) and is indicated for HIV infection. Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

Information about Emletra Junior 25 mg/100 mg Tablet (Brand: Emcure Pharmaceuticals Ltd) - Uses: HIV infection

Wishlist Add to cart

  • MRP: ₹ 1475.47
  • Packing: 60.0 tablets in 1 bottle
  • Salt Combination: Ritonavir (25mg) + Lopinavir (100mg)
  • Brand: Emcure Pharmaceuticals Ltd
  • Uses: HIV infection

Description

  • Emletra Junior 25 mg/100 mg Tablet is a combination of antiretrovirals medicines
  • It is prescribed to treat HIV (human immunodeficiency virus) infection
  • It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome)
  • Emletra Junior 25 mg/100 mg Tablet restricts the growth of HIV in the body and reduces the risk of getting HIV-related complications to improve the lifespan of an individual
  • The medicine should be taken with food for better efficacy
  • Taking these medicines regularly at the same time increases their effectiveness
  • A dose of this medicine should not be missed as it can affect your recovery
  • It is important to complete the full course of the treatment until your doctor advises you to stop it
  • Sudden discontinuation of the treatment may affect the potency of the medicine.
  • The most common side effects of this medicine are diarrhea, nausea, vomiting, and increased blood fat levels (hypertriglyceridemia and hypercholesterolemia)
  • These side effects are generally temporary, but if they persist or become serious inform your doctor
  • Drinking plenty of fluid can help you to cope up with these side effects, so stay hydrated
  • In addition to that, avoid alcohol consumption as it may increase the intensity of the side effects.
  • Before starting with the treatment, you should consult your doctor if you are pregnant or breastfeeding, or have any health condition
  • Your doctor may suggest regular laboratory tests to check your blood counts, kidney and liver functions, and other health conditions
  • If you are HIV positive, you should not breastfeed or share personal belongings like razors or toothbrushes
  • Consult your doctor to know about safe sex methods in order to prevent transmission of HIV during intercourse.

Cautions

Liver: CAUTION: Emletra Junior 25 mg/100 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Emletra Junior 25 mg/100 mg Tablet may be needed. Please consult your doctor.
Kidney: SAFE IF PRESCRIBED: Emletra Junior 25 mg/100 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Emletra Junior 25 mg/100 mg Tablet may not be needed in these patients. Please consult your doctor.
Driving: CONSULT YOUR DOCTOR: It is not known whether Emletra Junior 25 mg/100 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Breast feeding: SAFE IF PRESCRIBED: Emletra Junior 25 mg/100 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnency: CONSULT YOUR DOCTOR: Emletra Junior 25 mg/100 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol: CAUTION: Caution is advised when consuming alcohol with Emletra Junior 25 mg/100 mg Tablet. Please consult your doctor.
Drug Action: N/A
Therapeutic class: ANTI INFECTIVES
Habit Forming: No
Chemical Class: N/A

Uses

Uses of Emletra Junior 25 mg/100 mg Tablet

  • In HIV infection Emletra Junior 25 mg/100 mg Tablet prevents the HIV virus from multiplying in your body
  • It helps control the infection and makes your immune system work better
  • This lowers your chances of getting complications such as new infections and improves your quality of life
  • It is not a cure of HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk
  • It is important that you Take Emletra Junior 25 mg/100 mg Tablet as prescribed, following the dosage recommended by your doctor
  • Taking all doses in the right amount at the right times greatly increases the effectiveness of your combination of medicines and reduces the chances of your HIV infection becoming resistant to antiretroviral medicines
  • However, taking this medicine will not prevent you from passing HIV to other people.
Missed Doses
If you miss a dose of Emletra Junior 25 mg/100 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FAQs

Frequestly asked Questions

Side Effects

Common and Known Side effects of Emletra Junior 25 mg/100 mg Tablet
  • Taste change
  • Headache
  • Nausea
  • Vomiting
  • Diarrhea
  • Stomach pain
  • Increased liver enzymes
  • Increased blood lipid level
  • Peripheral neuropathy (tingling and numbness of feet and hand)

Reviews

Add your review




Alternate Medicines


No Product Found